CN103816367A - Traditional Chinese medicine for treating migraine - Google Patents
Traditional Chinese medicine for treating migraine Download PDFInfo
- Publication number
- CN103816367A CN103816367A CN201410078133.0A CN201410078133A CN103816367A CN 103816367 A CN103816367 A CN 103816367A CN 201410078133 A CN201410078133 A CN 201410078133A CN 103816367 A CN103816367 A CN 103816367A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- chinese medicine
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 208000019695 Migraine disease Diseases 0.000 title abstract description 7
- 206010027599 migraine Diseases 0.000 title abstract description 7
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 6
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 6
- 239000009670 cang er zi wan Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241001522723 Conoidea Species 0.000 claims description 5
- 244000166124 Eucalyptus globulus Species 0.000 claims description 5
- 235000004692 Eucalyptus globulus Nutrition 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 235000014435 Mentha Nutrition 0.000 claims description 5
- 241001072983 Mentha Species 0.000 claims description 5
- 241000125142 Seseli Species 0.000 claims description 5
- 241000219289 Silene Species 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000103090 Eucalyptus robusta Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000184734 Pyrus japonica Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241001097328 Seseli mairei Species 0.000 abstract 1
- 241000537173 Silene conoidea Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000005221 swamp mahogany Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000007902 hard capsule Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 206010020765 hypersomnia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine for treating migraine, which is characterized by being prepared from the following raw materials in parts by weight: 3-6 parts of mint, 2-4 parts of borneol, 6-10 parts of chrysanthemum, 2-3 parts of angelica sinensis, 3-7 parts of ligusticum wallichii, 2-5 parts of coptis chinensis, 2-6 parts of salvia miltiorrhiza, 3-5 parts of Sapanwood, 3-6 parts of longan, 1-5 parts of fructus xanthii, 3-6 parts of silene conoidea, 2-7 parts of ephdra vulgaris, 6-10 parts of eucalyptus robusta, 2-6 parts of liquorice, 2-4 parts of ophiopogon japonicas, 2-6 parts of acorus gramineus, 1-2 parts of fructus caryophylli, and 1-3 parts of seseli mairei. The traditional Chinese medicine has no toxic or side effects, is convenient to take, easy to absorb, and remarkable in curative effect, conforms to the national relevant standard after being tested, and has the characteristics of long-acting property and high efficiency; clinical application and observation proves that the traditional Chinese medicine takes effect quickly, the curative ratio is up to 95%, and no relapse occurs so far during the follow-up to cured patients.
Description
Technical field
The present invention relates to a kind of medicine, particularly one is treated migrainous Chinese medicine.
Background technology
Migraine shows as paroxysmal inclined to one side side pulsatile headache, companion feels sick, vomiting and photophobia, again fall ill through one section of after date of having a rest, the periodical attack disease of Shi Yileiyou family morbidity tendency, in quiet, dark surrounds or after sleep, headache is alleviated, can be with nerve, mental function disorder before headache occurs or when outbreak; Migraine has genetic predisposition, and migraineur has family history, and its relatives occur that migrainous risk is 3～6 times of population; Environmental factors also participates in migrainous outbreak.Migraine can be brought out by some food and medicine, in addition, high light, overwork, stress and stress after loosen, hypersomnia or very few, fasting, anxiety, emotional lability etc. be also migrainous risk factor.
At present in the migrainous medicine for the treatment of: although doctor trained in Western medicine is substantially effective in cure, side effect is large, cure the symptoms, not the disease, and expensive, cannot fundamentally cure migraine, brought very large misery to patient.
Summary of the invention
The present invention is in order to make up the deficiencies in the prior art, and a kind of good effect, side effect is little, cost the is low migrainous Chinese medicine for the treatment of are provided.
The present invention is achieved through the following technical solutions:
One is treated migrainous Chinese medicine, and its special character is: be to be made up of the raw material of following parts by weight:
3 ~ 6 parts of Herba Menthaes, 2 ~ 4 parts of Borneolum Syntheticums, 6 ~ 10 parts of Flos Chrysanthemis, 2 ~ 3 parts of Radix Angelicae Sinensis, 3 ~ 7 parts of Rhizoma Chuanxiongs, 2 ~ 5 parts of Herba Munroniae henryis, 2 ~ 6 parts of Radix Salviae Miltiorrhizaes, 3 ~ 5 parts of Lignum Sappans, 3 ~ 6 parts of Arillus Longan, 1 ~ 5 part of Fructus Xanthii, 3 ~ 6 parts of Herba Silenes conoideaes, 2 ~ 7 parts, Herba Ephedrae, 6 ~ 10 parts of Folium eucalypti globueli (Eucalyptus globulus Labill.)s, 2 ~ 6 parts, Radix Glycyrrhizae, 2 ~ 4 parts of Radix Ophiopogonis, 2 ~ 6 parts of Rhizoma Acori Graminei, 1 ~ 2 part of Fructus Caryophylli, 1 ~ 3 part of Radix Seselis mairei.
Preparation method of the present invention is as follows: above-mentioned Chinese medicine is mixed, and with Burdick lamp, it is carried out to sterilization processing; Then put into baking box medicine is dried, with pulverizer, medicine is pulverized, be then ground into powder face, pack 0.5 gram every stirring in incapsulating.
Usage and dosage: oral, every day twice, each two hard capsules.
Summary of Clinical Research data
Clinical observation:
(1) physical data:
The inventor in 2012 so far, carries out clinical observation treatment to 240 routine patients.Wherein male's 92 examples, women's 148 examples, the age 19 is to 74 years old, the migraine that a variety of causes causes.
(2) Therapeutic Method:
Oral, every day twice, each two hard capsules.
(3) efficacy assessment standard:
Cure: migrainous clinical symptoms sign disappears, it is normal that functional activity recovers.
Effective: basic or most of disappearance of migrainous clinical symptoms sign.
Effective: migrainous clinical symptoms is clearly better or takes a turn for the better.
Invalid: migrainous clinical symptoms sign is without improvement.
Therapeutic effect:
Clinical cure 227 examples, account for 95%; Effective 8 examples, account for 3%; Effective 3 examples, account for 1%; Invalid 2 examples, account for 1%; Total effective rate 99%, all cases all have no adverse reaction.
The invention has the beneficial effects as follows: have no side effect, taking convenience, be easy to absorb, evident in efficacy, meet relevant national standard through check, observation on Clinical Application confirms instant effect, has long-acting, efficient feature, cure rate is up to 95%, recurrence that healing person follows up a case by regular visits to that so far there are no.
The specific embodiment
Embodiment 1:
By 3 grams of Herba Menthaes, 2 grams of Borneolum Syntheticums, 8 grams of Flos Chrysanthemis, 3 grams of Radix Angelicae Sinensis, 3 grams of Rhizoma Chuanxiongs, 3 grams of Herba Munroniae henryis, 2 grams of Radix Salviae Miltiorrhizaes, 3 grams of Lignum Sappans, 4 grams of Arillus Longan, 2 grams of Fructus Xanthii, 3 grams of Herba Silenes conoideaes, 2 grams, Herba Ephedrae, 6 grams of Folium eucalypti globueli (Eucalyptus globulus Labill.)s, 3 grams, Radix Glycyrrhizae, 2 grams of Radix Ophiopogonis, 3 grams of Rhizoma Acori Graminei, 1 gram of Fructus Caryophylli, 1 gram of Radix Seselis mairei, all raw material mix homogeneously, and with ultraviolet, it is carried out to sterilization processing; Then put into baking box medicine is dried, with pulverizer, medicine is pulverized, be then ground into powder face, then stir to pack in hard capsule and pack, 0.5 gram every, oral, one day twice, each two hard capsules.
Embodiment 2:
By 4 grams of Herba Menthaes, 3 grams of Borneolum Syntheticums, 10 grams of Flos Chrysanthemis, 3 grams of Radix Angelicae Sinensis, 5 grams of Rhizoma Chuanxiongs, 2 grams of Herba Munroniae henryis, 4 grams of Radix Salviae Miltiorrhizaes, 4 grams of Lignum Sappans, 5 grams of Arillus Longan, 5 grams of Fructus Xanthii, 4 grams of Herba Silenes conoideaes, 6 grams, Herba Ephedrae, 8 grams of Folium eucalypti globueli (Eucalyptus globulus Labill.)s, 4 grams, Radix Glycyrrhizae, 3 grams of Radix Ophiopogonis, 5 grams of Rhizoma Acori Graminei, 1 gram of Fructus Caryophylli, 2 grams of Radix Seselis mairei, all raw material mix homogeneously, and with ultraviolet, it is carried out to sterilization processing; Then put into baking box medicine is dried, with pulverizer, medicine is pulverized, be then ground into powder face, then stir to pack in hard capsule and pack, 0.5 gram every, oral, one day twice, each two hard capsules.
Embodiment 3:
By 6 grams of Herba Menthaes, 4 grams of Borneolum Syntheticums, 10 grams of Flos Chrysanthemis, when 2 grams, 7 grams of Rhizoma Chuanxiongs, 5 grams of Herba Munroniae henryis, 6 grams of Radix Salviae Miltiorrhizaes, 5 grams of Lignum Sappans, 6 grams of Arillus Longan, 5 grams of Fructus Xanthii, 6 grams of Herba Silenes conoideaes, 7 grams, Herba Ephedrae, 10 grams of Folium eucalypti globueli (Eucalyptus globulus Labill.)s, 6 grams, Radix Glycyrrhizae, 4 grams of Radix Ophiopogonis, 6 grams of Rhizoma Acori Graminei, 2 grams of Fructus Caryophyllis, 3 grams of Radix Seselis mairei, all raw material mix homogeneously, and with ultraviolet, it is carried out to sterilization processing; Then put into baking box medicine is dried, with pulverizer, medicine is pulverized, be then ground into powder face, then stir to pack in hard capsule and pack, 0.5 gram every, oral, one day twice, each two hard capsules.
Claims (1)
1. the migrainous Chinese medicine for the treatment of, is characterized in that: be to be made up of the raw material of following parts by weight:
3 ~ 6 parts of Herba Menthaes, 2 ~ 4 parts of Borneolum Syntheticums, 6 ~ 10 parts of Flos Chrysanthemis, 2 ~ 3 parts of Radix Angelicae Sinensis, 3 ~ 7 parts of Rhizoma Chuanxiongs, 2 ~ 5 parts of Herba Munroniae henryis, 2 ~ 6 parts of Radix Salviae Miltiorrhizaes, 3 ~ 5 parts of Lignum Sappans, 3 ~ 6 parts of Arillus Longan, 1 ~ 5 part of Fructus Xanthii, 3 ~ 6 parts of Herba Silenes conoideaes, 2 ~ 7 parts, Herba Ephedrae, 6 ~ 10 parts of Folium eucalypti globueli (Eucalyptus globulus Labill.)s, 2 ~ 6 parts, Radix Glycyrrhizae, 2 ~ 4 parts of Radix Ophiopogonis, 2 ~ 6 parts of Rhizoma Acori Graminei, 1 ~ 2 part of Fructus Caryophylli, 1 ~ 3 part of Radix Seselis mairei.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410078133.0A CN103816367B (en) | 2014-03-05 | 2014-03-05 | One treats migrainous Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410078133.0A CN103816367B (en) | 2014-03-05 | 2014-03-05 | One treats migrainous Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103816367A true CN103816367A (en) | 2014-05-28 |
| CN103816367B CN103816367B (en) | 2016-03-23 |
Family
ID=50751847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410078133.0A Active CN103816367B (en) | 2014-03-05 | 2014-03-05 | One treats migrainous Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103816367B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106362010A (en) * | 2016-11-11 | 2017-02-01 | 成都悦伦商贸有限公司 | Preparation method of traditional Chinese medicine agentia for treating migraine without aura |
| CN106377679A (en) * | 2016-11-11 | 2017-02-08 | 成都悦伦商贸有限公司 | Traditional Chinese medicinal composition for treating non-premonitory migraine |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1270043A (en) * | 2000-01-27 | 2000-10-18 | 冀承环 | Medicine for treating hemicrania |
| CN101695566A (en) * | 2009-10-27 | 2010-04-21 | 胡艳梅 | Chinese medicament for treating cephalagra |
| CN102579986A (en) * | 2012-02-29 | 2012-07-18 | 候爱武 | Chinese medicinal pain-removing mixture for treating migraine |
-
2014
- 2014-03-05 CN CN201410078133.0A patent/CN103816367B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1270043A (en) * | 2000-01-27 | 2000-10-18 | 冀承环 | Medicine for treating hemicrania |
| CN101695566A (en) * | 2009-10-27 | 2010-04-21 | 胡艳梅 | Chinese medicament for treating cephalagra |
| CN102579986A (en) * | 2012-02-29 | 2012-07-18 | 候爱武 | Chinese medicinal pain-removing mixture for treating migraine |
Non-Patent Citations (1)
| Title |
|---|
| 杨明山: "偏头痛的药物治疗进展", 《医药导报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106362010A (en) * | 2016-11-11 | 2017-02-01 | 成都悦伦商贸有限公司 | Preparation method of traditional Chinese medicine agentia for treating migraine without aura |
| CN106377679A (en) * | 2016-11-11 | 2017-02-08 | 成都悦伦商贸有限公司 | Traditional Chinese medicinal composition for treating non-premonitory migraine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103816367B (en) | 2016-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102302751B (en) | Chinese medicine for treating migraine | |
| CN103550496A (en) | Traditional Chinese medicine for treating migraine | |
| CN103041285A (en) | Cerebral apoplexy commemorative sign treatment method by utilizing Chinese medicaments | |
| CN101695566A (en) | Chinese medicament for treating cephalagra | |
| CN103816367B (en) | One treats migrainous Chinese medicine | |
| CN101297950A (en) | Chinese medicine for preventing and treating atherosclerosis, coronary disease and preparation thereof | |
| CN103463583A (en) | Gastrointestinal disease treatment Chinese herbal | |
| CN101991807A (en) | Chinese herbal compound for treating liver cancer | |
| CN101623455B (en) | Medicine for treating prostate hyperplasia | |
| CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
| CN102166323A (en) | Medicine for curing burn and preparation method thereof | |
| CN102961647A (en) | Traditional Chinese medicine for treating osteoporosis | |
| CN103341137B (en) | Formula and preparation method of traditional Chinese medicine for treating cancers | |
| CN102048930A (en) | Formula of traditional Chinese medicine for treating chronic gastritis | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN101317934B (en) | Chinese medicine for treating chronic sinusitis | |
| CN1261130C (en) | Medicine for dispelling tinea | |
| CN104274706A (en) | Traditional Chinese medicine mixture for treating radioactive stomatitis | |
| CN102973694A (en) | Traditional Chinese medicine formula for treating constipation, and preparation method thereof | |
| CN102641413A (en) | Medicine for treating acute enteritis and preparing method thereof | |
| CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
| CN102397319A (en) | Medicament for treating pertussis | |
| CN101569726A (en) | Chinese medicament for treating fracture contusion | |
| CN102284029B (en) | Traditional Chinese medicine for treating migraine | |
| CN101773554A (en) | Medicine for treating high blood pressure and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Huang Meiying Inventor after: Huang Junying Inventor before: Zhang Zhiwei |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160225 Address after: 274000 No. 3099 Bayi Road, Mudan District, Shandong, Heze Applicant after: Liu Ruiying Address before: Room 9, building No. 4569, No. 250101, Fenghuang Road, high tech Zone, Shandong, Ji'nan, China Applicant before: Jinan Weichuan Information Technology Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information |
Inventor after: Han Weiwei Inventor before: Huang Meiying Inventor before: Huang Junying |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170818 Address after: 253600 Shandong city of Leling province Xiaowu An Zhen Han Yang Village No. 123 Patentee after: Han Weiwei Address before: 274000 No. 3099 Bayi Road, Mudan District, Shandong, Heze Patentee before: Liu Ruiying |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180403 Address after: 226100 Jiangsu city of Nantong Province Haimen Haimen Textile Industrial Park Avenue South are Dieshiqiao electric mall 3 floor Patentee after: Haimen Huaxia Li Li Network Technology Service Co., Ltd. Address before: 253600 Shandong city of Leling province Xiaowu An Zhen Han Yang Village No. 123 Patentee before: Han Weiwei |
|
| TR01 | Transfer of patent right |